Cargando…
Tirofiban shows better platelet inhibition in diabetic patients during PCI procedures
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592321/ https://www.ncbi.nlm.nih.gov/pubmed/20532446 |
Ejemplares similares
-
Mean platelet volume is associated with myocardial perfusion defect in diabetic patients
por: Sarikaya, Savas, et al.
Publicado: (2014) -
Colour M-mode superiority in evaluation of improvement in myocardial performance indices following successful percutaneous coronary intervention (PCI)
por: Sattarzadeh, R, et al.
Publicado: (2011) -
Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry
por: Knot, Jiri, et al.
Publicado: (2012) -
Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016) -
Decline in mean platelet volume in patients with patent foramen ovale undergoing percutaneous closure
por: Düzel, Bariş, et al.
Publicado: (2014)